CHOSA Oncology
CHOSA Oncology AB payback of convertible loan in process
REG
CEO Peter Buhl comments: "The initiation process in ongoing but has unfortunately caused us more administrative challenges than we had hoped for. I want to apologize for any inconvenience this may cause and again thank you all for your patience."
This disclosure contains information that Chosa Oncology AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 18-04-2023 14:45 CET.
| Datum | 2023-04-18, kl 14:45 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!